TLRs1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections
© 2024 The Author(s). Published by S. Karger AG, Basel..
INTRODUCTION: Toll-like receptors play crucial roles in the sepsis-induced systemic inflammatory response. Septic shock mortality correlates with overexpression of neutrophilic TLR2 and TLR9, while the role of TLR4 overexpression remains a debate. In addition, TLRs are involved in the pathogenesis of viral infections such as COVID-19, where the single-stranded RNA of SARS-CoV-2 is recognized by TLR7 and TLR8, and the spike protein activates TLR4.
METHODS: In this study, we conducted a comprehensive analysis of TLRs 1-10 expressions in white blood cells from 71 patients with bacterial and viral infections. Patients were divided into 4 groups based on disease type and severity (sepsis, septic shock, moderate, and severe COVID-19) and compared to 7 healthy volunteers.
RESULTS: We observed a significant reduction in the expression of TLR4 and its co-receptor CD14 in septic shock neutrophils compared to the control group (p < 0.001). Severe COVID-19 patients exhibited a significant increase in TLR3 and TLR7 levels in neutrophils compared to controls (p < 0.05). Septic shock patients also showed a similar increase in TLR7 in neutrophils along with elevated intermediate monocytes (CD14+CD16+) compared to the control group (p < 0.005 and p < 0.001, respectively). However, TLR expression remained unchanged in lymphocytes.
CONCLUSION: This study provides further insights into the mechanisms of TLR activation in various infectious conditions. Additional analysis is needed to assess their correlation with patient outcome and to evaluate the impact of TLR-pathway modulation during septic shock and severe COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Journal of innate immunity - 16(2024), 1 vom: 26., Seite 216-225 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chomel, Louise [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.04.2024 Date Revised 24.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1159/000536593 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369515404 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369515404 | ||
| 003 | DE-627 | ||
| 005 | 20240425233110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240311s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000536593 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM369515404 | ||
| 035 | |a (NLM)38461810 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chomel, Louise |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a TLRs1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.04.2024 | ||
| 500 | |a Date Revised 24.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Author(s). Published by S. Karger AG, Basel. | ||
| 520 | |a INTRODUCTION: Toll-like receptors play crucial roles in the sepsis-induced systemic inflammatory response. Septic shock mortality correlates with overexpression of neutrophilic TLR2 and TLR9, while the role of TLR4 overexpression remains a debate. In addition, TLRs are involved in the pathogenesis of viral infections such as COVID-19, where the single-stranded RNA of SARS-CoV-2 is recognized by TLR7 and TLR8, and the spike protein activates TLR4 | ||
| 520 | |a METHODS: In this study, we conducted a comprehensive analysis of TLRs 1-10 expressions in white blood cells from 71 patients with bacterial and viral infections. Patients were divided into 4 groups based on disease type and severity (sepsis, septic shock, moderate, and severe COVID-19) and compared to 7 healthy volunteers | ||
| 520 | |a RESULTS: We observed a significant reduction in the expression of TLR4 and its co-receptor CD14 in septic shock neutrophils compared to the control group (p < 0.001). Severe COVID-19 patients exhibited a significant increase in TLR3 and TLR7 levels in neutrophils compared to controls (p < 0.05). Septic shock patients also showed a similar increase in TLR7 in neutrophils along with elevated intermediate monocytes (CD14+CD16+) compared to the control group (p < 0.005 and p < 0.001, respectively). However, TLR expression remained unchanged in lymphocytes | ||
| 520 | |a CONCLUSION: This study provides further insights into the mechanisms of TLR activation in various infectious conditions. Additional analysis is needed to assess their correlation with patient outcome and to evaluate the impact of TLR-pathway modulation during septic shock and severe COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a News | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Monocytes | |
| 650 | 4 | |a Neutrophils | |
| 650 | 4 | |a Septic shock | |
| 650 | 4 | |a Toll-like receptors | |
| 650 | 7 | |a Toll-Like Receptors |2 NLM | |
| 650 | 7 | |a Toll-Like Receptor 1 |2 NLM | |
| 650 | 7 | |a TLR10 protein, human |2 NLM | |
| 650 | 7 | |a Lipopolysaccharide Receptors |2 NLM | |
| 650 | 7 | |a TLR1 protein, human |2 NLM | |
| 650 | 7 | |a Toll-Like Receptor 7 |2 NLM | |
| 650 | 7 | |a Toll-Like Receptor 10 |2 NLM | |
| 700 | 1 | |a Vogt, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Demiselle, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Le Borgne, Pierrick |e verfasserin |4 aut | |
| 700 | 1 | |a Tschirhart, Marine |e verfasserin |4 aut | |
| 700 | 1 | |a Morandeau, Valentin |e verfasserin |4 aut | |
| 700 | 1 | |a Merdji, Hamid |e verfasserin |4 aut | |
| 700 | 1 | |a Miguet, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Helms, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Meziani, Ferhat |e verfasserin |4 aut | |
| 700 | 1 | |a Mauvieux, Laurent |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of innate immunity |d 2009 |g 16(2024), 1 vom: 26., Seite 216-225 |w (DE-627)NLM187392943 |x 1662-8128 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:1 |g day:26 |g pages:216-225 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000536593 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 1 |b 26 |h 216-225 | ||